Abbott Laboratories
AbbVie Inc
AstraZeneca PLC
Bayer AG
Biocon
Eli Lilly and Company
Merck KGaA
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company Limited
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2024 | 197 | Diligence Insights | ASDR-667500 |
Abbott Laboratories
AbbVie Inc
AstraZeneca PLC
Bayer AG
Biocon
Eli Lilly and Company
Merck KGaA
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Sanofi
Takeda Pharmaceutical Company Limited